Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials
- PMID: 23810887
- DOI: 10.1016/j.jacc.2013.05.067
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials
Comment on
-
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.J Am Coll Cardiol. 2013 Jun 4;61(22):2264-73. doi: 10.1016/j.jacc.2013.03.020. Epub 2013 Apr 3. J Am Coll Cardiol. 2013. PMID: 23562920
-
Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.J Am Coll Cardiol. 2013 Sep 3;62(10):945-6. doi: 10.1016/j.jacc.2013.05.066. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810890 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical